Access cutting-edge gvhd treatment through this clinical trial at a research site in Kansas City. Study-provided care at no cost to qualified participants.
Access gvhd specialists in Kansas City at no cost
This study follows strict safety protocols and ethical guidelines
All study-related gvhd treatment provided free
The purpose of this study is to determine whether the carbohydrate prebiotic (dietary supplement) known as galacto-oligosaccharide (GOS) can modulate the microbiome (the bacteria in the gut) and help prevent graft-versus host disease (GVHD) after allogeneic stem cell transplant. The study has two two parts. In phase 1, the best dose of GOS will be evaluated. In phase 2, using the best dose of GOS, participants will be randomized to receive GOS or a placebo (maltodextrin, a common food additive t
Sponsor: Duke University
Check if you qualify for this gvhd clinical trial in Kansas City, KS
If you're searching for gvhd treatment options in Kansas City, KS, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Kansas City research site is actively enrolling participants for this clinical trial. You'll receive care from experienced gvhd specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.